Although migraine prevalence in the United States has stayed steady over the past three decades, the proportion of patients reporting chronic headache is increasing, new research shows.
Study results now extend evidence on the safety of of triptans for migraine in pregnancy and should reassure women who need to take this class of drugs while expecting.
Women with a history of migraine are at increased risk for preeclampsia, gestational hypertension, and other adverse pregnancy outcomes, new research suggests.
Young women may be at a higher risk of ischemic stroke than young men, a new systematic review shows, representing a significant departure from our current scientific understanding, researchers say.
Erenumab significantly reduces the number of monthly migraine days and use of acute migraine-specific medication in patients with episodic or chronic migraine, regardless of aura status.